Éú³¤ÒÖËؼ°µ°°×øÒÖÖƼÁÓÃÓÚÔ¤·ÀERCPÊõºóÒÈÏÙÑ×¼°¸ßµí·ÛøѪ֢µÄ±´Ò¶Ë¹Íø×´Meta·ÖÎö(8)
[41] GUELRUD M£¬ MENDOZA S£¬ VIERA L£¬ et al. Somatostatin prevents acute pancreatitis after pancreatic duct sphincter hydrostatic balloon dilation in patients with idiopathic recurrent pancreatitis[J]. Gastrointest Endosc£¬1991£¬ 37(1)£º44-47.
[42] BORDAS JM£¬ TOLEDO V£¬ MONDELO F£¬ et al. Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangio-pancreatography and endoscopic sphincterotomy.[J]. Horm Res Paedia£¬1988£¬29(2/3)£º106-108.
[43] BORDAS J£¬ TOLEDO-PIMENTEL V£¬ LLACH J£¬ et al. Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography£º results of a randomized study[J]. Gastrointest Endosc£¬ 1998£¬ 47(3)£º230-234.
[44] SAARI A£¬ KIVILAAKSO E£¬ SCHRODER T. The influence of somatostatin on pancreatic irritation after pancreatography£ºan experimental and clinical study[J]. Surg Res Comm£¬1988£¬ 2(4)£º271-278.
[45] ANDRIULLI A£¬ LEANDRO G£¬ FEDERICI T£¬ et al. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP£º an updated meta-analysis[J]. Gastrointest Endosc£¬ 2007£¬ 65(4)£º624- 632.
[46] XIE Q£¬ LEI WS£¬ XING ZX£¬ et al. Prophylactic Effect of Somatostatin in Preventing Post-ERCP Pancreatitis£º an updated meta-analysis[J]. Saudi J Gastroenterol£¬ 2015£¬ 21(6)£º372-378.
[47] Å˘䲨£¬ ¹¢Ð¡Æ½. Éú³¤ÒÖËØÔ¤·ÀÄÚ¾µÄæÐÐÒȵ¨¹ÜÔìÓ°ÊõºóÒÈÏÙÑ×Ч¹ûµÄMeta·ÖÎö[J]. ÖлªÍâ¿ÆÔÓÖ¾£¬ 2016£¬ 54(6)£º466-472.
[48] SETA T£¬ NOGUCHI Y. Protease inhibitors for preventing complications associated with ERCP£º an updated meta-analysis[J]. Gastrointest Endosc£¬ 2011£¬ 73(4)£º700- 706.
[49] ZHANG ZF£¬ YANG N£¬ ZHAO G£¬ et al. Preventive effect of ulinastatin and gabexate mesylate on post-endoscopic retrograde cholangiopancreatography pancreatitis.[J]. Chin Med J (Engl)£¬ 2010£¬ 123(18)£º2600-2606.
[50] YUHARA H£¬ OGAWA M£¬ KAWAGUCHI Y£¬ et al. Pharmacologic prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis£º protease inhibitors and NSAIDs in a meta-analysis.[J]. J Gastroenterol£¬ 2014£¬ 49(3)£º388-399.
[51] Å˻ۣ¬ ÕÅÓîÁú£¬ »ÆÏþ¿¡£¬µÈ. µ°°×øÒÖÖƼÁÔ¤·ÀÄÚ¾µÄæÐÐÒȵ¨¹ÜÔìÓ°ÊõºóÒÈÏÙÑ×µÄMeta·ÖÎö[J]. ÖйúÄÚ¾µÔÓÖ¾£¬ 2012£¬ 18(11)£º1138-1146.
[52] ÖìÒÁõ.ÝÁĪ˾ËûÔ¤·ÀERCPÊõºóÒÈÏÙÑ×µÄMeta·ÖÎö[D]. ÄÏÄþ£º¹ãÎ÷Ò½¿Æ´óѧ£¬2015.
(ÊÕ¸åÈÕÆÚ£º2018-01-08 ÐÞ»ØÈÕÆÚ£º2018-03-08)
(±à¼£ºËï ±ù), °ÙÄ´Ò½Ò©(³Â½¡¸Õ Õŵ¤µ¤ ÂÀÐñ·å ÑîÔÃ)
[42] BORDAS JM£¬ TOLEDO V£¬ MONDELO F£¬ et al. Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangio-pancreatography and endoscopic sphincterotomy.[J]. Horm Res Paedia£¬1988£¬29(2/3)£º106-108.
[43] BORDAS J£¬ TOLEDO-PIMENTEL V£¬ LLACH J£¬ et al. Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography£º results of a randomized study[J]. Gastrointest Endosc£¬ 1998£¬ 47(3)£º230-234.
[44] SAARI A£¬ KIVILAAKSO E£¬ SCHRODER T. The influence of somatostatin on pancreatic irritation after pancreatography£ºan experimental and clinical study[J]. Surg Res Comm£¬1988£¬ 2(4)£º271-278.
[45] ANDRIULLI A£¬ LEANDRO G£¬ FEDERICI T£¬ et al. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP£º an updated meta-analysis[J]. Gastrointest Endosc£¬ 2007£¬ 65(4)£º624- 632.
[46] XIE Q£¬ LEI WS£¬ XING ZX£¬ et al. Prophylactic Effect of Somatostatin in Preventing Post-ERCP Pancreatitis£º an updated meta-analysis[J]. Saudi J Gastroenterol£¬ 2015£¬ 21(6)£º372-378.
[47] Å˘䲨£¬ ¹¢Ð¡Æ½. Éú³¤ÒÖËØÔ¤·ÀÄÚ¾µÄæÐÐÒȵ¨¹ÜÔìÓ°ÊõºóÒÈÏÙÑ×Ч¹ûµÄMeta·ÖÎö[J]. ÖлªÍâ¿ÆÔÓÖ¾£¬ 2016£¬ 54(6)£º466-472.
[48] SETA T£¬ NOGUCHI Y. Protease inhibitors for preventing complications associated with ERCP£º an updated meta-analysis[J]. Gastrointest Endosc£¬ 2011£¬ 73(4)£º700- 706.
[49] ZHANG ZF£¬ YANG N£¬ ZHAO G£¬ et al. Preventive effect of ulinastatin and gabexate mesylate on post-endoscopic retrograde cholangiopancreatography pancreatitis.[J]. Chin Med J (Engl)£¬ 2010£¬ 123(18)£º2600-2606.
[50] YUHARA H£¬ OGAWA M£¬ KAWAGUCHI Y£¬ et al. Pharmacologic prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis£º protease inhibitors and NSAIDs in a meta-analysis.[J]. J Gastroenterol£¬ 2014£¬ 49(3)£º388-399.
[51] Å˻ۣ¬ ÕÅÓîÁú£¬ »ÆÏþ¿¡£¬µÈ. µ°°×øÒÖÖƼÁÔ¤·ÀÄÚ¾µÄæÐÐÒȵ¨¹ÜÔìÓ°ÊõºóÒÈÏÙÑ×µÄMeta·ÖÎö[J]. ÖйúÄÚ¾µÔÓÖ¾£¬ 2012£¬ 18(11)£º1138-1146.
[52] ÖìÒÁõ.ÝÁĪ˾ËûÔ¤·ÀERCPÊõºóÒÈÏÙÑ×µÄMeta·ÖÎö[D]. ÄÏÄþ£º¹ãÎ÷Ò½¿Æ´óѧ£¬2015.
(ÊÕ¸åÈÕÆÚ£º2018-01-08 ÐÞ»ØÈÕÆÚ£º2018-03-08)
(±à¼£ºËï ±ù), °ÙÄ´Ò½Ò©(³Â½¡¸Õ Õŵ¤µ¤ ÂÀÐñ·å ÑîÔÃ)